WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
Laboratory of Data Discovery for Health Limited, Hong Kong Science and Technology Park, New Territories, Hong Kong Special Administrative Region, China.
Epidemiol Infect. 2022 Nov 4;150:e198. doi: 10.1017/S0950268822001753.
Annual seasonal influenza vaccination is recommended for individuals at high risk of developing post-infection complications in many locations. However, reduced vaccine immunogenicity and effectiveness have been observed among repeat vaccinees in some influenza seasons. We investigated the impact of repeated influenza vaccination on relative vaccine effectiveness (VE) among individuals who were recommended for influenza vaccination in the United Kingdom with a retrospective cohort study using primary healthcare data from the Clinical Practice Research Datalink, a primary care database in the United Kingdom. Relative VE was estimated against general practitioner-diagnosed influenza-like illnesses (GP-ILI) and medically attended acute respiratory illnesses (MAARI) among participants who have been repeatedly vaccinated compared with first-time vaccinees using proportional hazards models. Relative VE against MAARI may be reduced for individuals above 65 years old who were vaccinated in the current and previous influenza seasons for some influenza seasons. However, these findings were not conclusive as we could not exclude the possibility of residual confounding in our dataset. The use of routinely collected data from electronic health records to examine the effects of repeated vaccination needs to be complemented with sufficient efforts to include negative control outcomes to rule out residual confounding.
在许多地方,建议高感染后并发症风险人群每年接种季节性流感疫苗。然而,在某些流感季节,重复接种疫苗者的疫苗免疫原性和有效性降低。我们利用英国临床实践研究数据链(英国初级保健数据库)中的初级保健数据,进行了一项回顾性队列研究,调查了在英国推荐接种流感疫苗的人群中,重复接种流感疫苗对相对疫苗有效性(VE)的影响。通过比例风险模型,比较了重复接种疫苗者与初次接种疫苗者的相对 VE,针对普通科医生诊断的流感样疾病(GP-ILI)和因急性呼吸道疾病就医(MAARI)。对于当前和前一个流感季节接种疫苗的 65 岁以上人群,某些流感季节中针对 MAARI 的相对 VE 可能降低。然而,由于我们无法排除数据集中存在残余混杂的可能性,因此这些发现还没有定论。使用电子健康记录中的常规收集数据来检查重复接种的效果,需要辅以足够的努力,包括阴性对照结果,以排除残余混杂。